In addition, the OS showed a slight trend towards superiority of SRT with chemo over SRT without chemo, although these differences were not statistically significant ( p = 0.35).
← all excerpts
Clinical evaluation of stereotactic radiation therapy for recurrent or second primary mediastinal lymph node metastases originating from non-small cell lung cancer.
1
—
—